Amisulpride and Panic attack - a phase IV clinical study of FDA data

Summary:

Panic attack is reported as a side effect among people who take Amisulpride (amisulpride), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Clozaril, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Panic attack when taking Amisulpride. It is created by eHealthMe based on reports of 6,364 people who have side effects when taking Amisulpride from the FDA, and is updated regularly.

What is Amisulpride?

Amisulpride has active ingredients of amisulpride. eHealthMe is studying from 6,389 Amisulpride users. Check the latest studies of Amisulpride.

What is Panic attack?

Panic attack is found to be associated with 2,483 drugs and 2,081 conditions by eHealthMe. Check the latest studies of Panic attack.

On Apr, 25, 2026

6,364 people reported to have side effects when taking Amisulpride.
Among them, 25 people (0.39%) have Panic attack.

Among these 25 people:

How long have people been on Amisulpride when they have Panic attack? *

What is the gender of people who have Panic attack when taking Amisulpride? *

female: 31.82 %
male: 68.18 %

What is the age of people who have Panic attack when taking Amisulpride? *

What are other drugs people take besides Amisulpride? *

What are other side effects people have besides Panic attack? *

Suicidal Ideation: 12 people, 48.00%
Dizziness: 11 people, 44.00%
Drug Ineffective: 9 people, 36.00%
Apathy: 9 people, 36.00%
Irritability: 7 people, 28.00%
Nausea (feeling of having an urge to vomit): 7 people, 28.00%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 7 people, 28.00%
Withdrawal Syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance): 7 people, 28.00%
Stress And Anxiety: 6 people, 24.00%
Drowsiness: 6 people, 24.00%

What are the existing conditions these people have? *

Stress And Anxiety: 8 people, 32.00%
Depression: 6 people, 24.00%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 5 people, 20.00%
Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 1 person, 4.00%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 4.00%
Psychotic Disorder: 1 person, 4.00%
Post-Traumatic Stress Disorder: 1 person, 4.00%
Moebius Ii Syndrome (a rare neurological condition that primarily affects the muscles that control facial expression and eye movement): 1 person, 4.00%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 1 person, 4.00%
Affective Disorder (mental disorder): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Amisulpride and have Panic attack?

- Check whether Panic attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amisulpride:

Amisulpride (6,389 reports)

Panic attack treatments and more:

Panic attack (65,703 reports)

Browse all side effects of Amisulpride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic attack:

Panic attack (2,483 drugs)

Browse all the conditions that are associated with Panic attack:

Panic attack (2,081 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amisulpride (the active ingredients of Amisulpride) and Amisulpride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.